文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

基于双免疫标志物动态轨迹识别脓毒症不同免疫亚型

Identification of distinct immune subtypes in sepsis through dual immunomarker trajectory.
PubMed 文献 · Ann Intensive Care · 2026-02-20
一句话结论根据ICU入住4天内CRP与淋巴细胞绝对计数的动态轨迹,可将脓毒症分为免疫稳态、免疫抑制和免疫失衡三个亚型,各亚型预后与免疫特征显著不同。

本研究纳入三个队列共3223例成人脓毒症患者,要求ICU入住4天内至少测量三次CRP和淋巴细胞绝对计数。采用基于组的多轨迹模型对推导队列471例患者进行聚类,识别出免疫稳态亚型(39例,8.3%)、免疫抑制亚型(180例,38.2%)和免疫失衡亚型(252例,53.5%),并在内部验证队列(2527例)和外部验证队列(225例)中保持稳健。免疫稳态亚型病情最轻、PICS发生率和死亡率最低;免疫抑制亚型合并症更多、住院时间更长、死亡率更高;免疫失衡亚型病情最重、并发症更多、ICU住院时间更长、PICS发生率和死亡率最高。各亚型具有不同的免疫学特征,该分类补充了现有共识内型,作者认为尤其适用于资源有限环境。

要点

  • 基于CRP和淋巴细胞绝对计数动态轨迹可将脓毒症分为免疫稳态(8.3%)、免疫抑制(38.2%)和免疫失衡(53.5%)三个亚型。
  • 免疫失衡亚型病情最重,并发症更多、ICU住院时间更长、PICS发生率和死亡率最高。
  • 免疫抑制亚型合并症更多、住院时间更长、死亡率高于免疫稳态亚型。
  • 免疫稳态亚型病情最轻,PICS发生率和死亡率最低,免疫特征接近正常。
  • 该分类在内部验证队列(2527例)和外部验证队列(225例)中保持稳健,作者认为尤其适用于资源有限环境。

适用人群与场景

  • 三个队列共3223例成人脓毒症患者,要求在ICU入住后4天内至少测量三次CRP和淋巴细胞绝对计数。
  • 推导队列471例,内部验证队列2527例,外部验证队列225例。

诊断标准与关键阈值

  • 基于ICU入住后4天内CRP和淋巴细胞绝对计数的动态变化,采用基于组的多轨迹模型进行聚类,最优分类为三个亚型。
  • 免疫稳态亚型39例(8.3%),免疫抑制亚型180例(38.2%),免疫失衡亚型252例(53.5%)。

研究设计与关键结果

  • 研究类型为基于三个队列的脓毒症免疫分型研究,推导队列471例、内部验证队列2527例、外部验证队列225例,共3223例成人脓毒症患者。
  • 免疫稳态亚型病情最轻,PICS发生率和死亡率最低;免疫抑制亚型合并症更多、住院时间更长、死亡率更高;免疫失衡亚型病情最重,并发症更多、ICU住院时间更长、PICS发生率和死亡率最高。
  • 免疫稳态亚型表现为炎症消退和接近正常的免疫;免疫抑制亚型表现为淋巴细胞亚群普遍减少、早期T细胞持续活化以及最高程度的T细胞抑制;免疫失衡亚型表现为细胞因子风暴以及最严重的固有免疫和适应性免疫受损,表现为单核细胞HLA-DR表达显著降低和晚期T细胞活化缺陷。
  • 该分类在内部验证队列(2527例)和外部验证队列(225例)中保持稳健。

证据类型、等级与局限

  • 证据类型:基于三个队列的脓毒症免疫分型研究,采用基于组的多轨迹模型聚类。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于CRP和淋巴细胞绝对计数纵向动态的免疫分型提供了一种简单、临床可操作的方法,尤其适用于资源有限环境。
  • 作者认为,这些免疫亚型补充了现有共识内型。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While endotyping approaches have enhanced precision immunotherapy in sepsis, their temporal instability limits consistent clinical application. To overcome this challenge, the current study utilizes longitudinal immune markers to derive clinically relevant classifications.

METHODS: This study included three cohorts of 3,223 adult septic patients with at least three measurements of two readily available longitudinal immune markers, C-reactive protein (CRP) and absolute lymphocyte count (ALC), within four days following ICU admission. Group-based multi-trajectory modeling was used to cluster sepsis patients based on the dynamic changes of CRP and ALC to identify potential immune subgroups. Comparisons of clinical characteristics, hospital mortality, and persistent inflammation immunosuppression catabolism syndrome (PICS) incidence were made across the derived subgroups. We further characterized the immune-specific properties of each subgroup using 28 immune markers.

RESULTS: Based on the optimal classification, 471 sepsis patients in the derivation cohort were categorized into three subgroups: immune homeostasis subgroup (n = 39, 8.3%), immunosuppression subgroup (n = 180, 38.2%), and immune imbalance subgroup (n = 252, 53.5%). This classification remained robust upon validation in both internal (n = 2,527) and external (n = 225) cohorts. Differences in clinical profiles were observed in these subgroups: the immune homeostasis subgroup had the mildest disease severity with the lowest rates of PICS and mortality; the immunosuppression subgroup featured more chronic comorbidities, longer hospital stays, and higher mortality; while the immune imbalance subgroup exhibited the most critical condition, with more complications, longer ICU stays, and the highest incidence of PICS and mortality. Immune features revealed distinct subtype properties: the immune homeostasis subgroup exhibited inflammatory resolution and near-normal immunity; the immunosuppression subgroup characterized by a general reduction in lymphocyte subsets, persistent early T-cell activation, and the highest degree of T cell inhibition; and the immune imbalance subgroup showed a cytokine storm alongside the most severely impaired innate and adaptive immunity, as indicated by markedly low monocyte human leukocyte antigen-DR (mHLA-DR) expression and deficient late T cell activation.

CONCLUSIONS: This study presents a practical immunological classification for sepsis based on the longitudinal dynamics of two immune markers. These immune subtypes complement existing consensus endotypes and provide a simple, clinically actionable approach particularly applicable in resource-limited settings.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Pei F, Liu N, Yuan J, et al. Identification of distinct immune subtypes in sepsis through dual immunomarker trajectory. Ann Intensive Care. 2026. PMID: 41938896. doi:10.1016/j.aicoj.2026.100039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。